{"id":"W4388048272","doi":"10.1136/jitc-2023-sitc2023.0766","title":"766 A clinical trial to evaluate the safety, tolerability and preliminary efficacy of VG161 in combination with Nivolumab in patients with advanced pancreatic cancer","year":2023,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"ca_institutions":"Vancouver Biotech (Canada)","funders":"","keywords":"Tolerability; Medicine; Pharmacodynamics; Nivolumab; Oncolytic virus; Internal medicine; Pharmacokinetics; Gastroenterology; Refractory (planetary science); Pancreatic cancer; Adverse effect; Cancer; Oncology; Urology; Pharmacology; Immunotherapy; Biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007720109,0.0006116524,0.001106107,0.0001866885,0.00026279,0.0006848984,0.0004103614,0.0007652088,0.003770207],"category_scores_gemma":[0.0003924847,0.0002381097,0.0007672167,0.0002334978,0.0005947063,0.0004749921,0.0001937367,0.00162855,0.000772005],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006301521,"about_ca_system_score_gemma":0.001107845,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006963836,"about_ca_topic_score_gemma":0.001850275,"domain_scores_codex":[0.9997547,0.0001146876,0.00001377908,0.00003945169,0.00002529497,0.00005205876],"domain_scores_gemma":[0.9997122,0.00005130004,0.00005280224,0.00002403898,0.00001501091,0.0001446768],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.7765579,0.03578946,0.006435923,0.0006490243,0.0007447383,0.0002886841,0.0001518264,0.002689295,0.06281988,0.0002367867,0.002539608,0.1110969],"study_design_scores_gemma":[0.3387785,0.638162,0.009858607,0.00003538429,0.0002470571,0.0003086501,0.00005365473,0.001373515,0.007534832,0.0002163872,0.003404039,0.00002750486],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.994902,0.001442764,0.0002062292,0.0002329163,0.00008584281,0.0009843369,0.0004494279,0.00004663242,0.001649912],"genre_scores_gemma":[0.9945852,0.0007132972,0.0007634585,0.0003751784,0.00007885121,0.0007561625,0.0007768262,0.00001516745,0.001935875],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003770207,"threshold_uncertainty_score":0.01261258,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02569682065945692,"score_gpt":0.331014626253827,"score_spread":0.3053178055943701,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}